Clinical Trial Update: A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma [Phase 1]

View source ↗

Summary

Phase 1 results update for itolizumab (EQ001) evaluating safety, tolerability, pharmacokinetics/pharmacodynamics, and clinical activity in adults with uncontrol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Itolizumab (EQ001) (Itolizumab)

Snippet

Sponsor: Equillium | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2025-04-18